We are live on ! Find out more
Harris Associates

Harris Associates Portfolio holdings

AUM $75B
1-Year Est. Return 11.27%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+11.27%
3 Year Est. Return
+52.81%
5 Year Est. Return
+73.58%
10 Year Est. Return
+314.39%
AUM
$58B
AUM Growth
+$6.64B
Cap. Flow
+$170M
Cap. Flow %
0.29%
Top 10 Hldgs %
35.75%
Holding
148
New
14
Increased
45
Reduced
73
Closed
5

Top Buys

Rank Stock Value
1
PSX icon
Phillips 66
PSX
+$597M
2
CNC icon
Centene
CNC
+$496M
3
CNH
CNH Industrial
CNH
+$418M
4
IQV icon
IQVIA
IQV
+$379M
5
AXP icon
American Express
AXP
+$336M

Top Sells

Rank Stock Value
1
PH icon
Parker-Hannifin
PH
+$436M
2
KKR icon
KKR & Co
KKR
+$417M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$373M
4
AMZN icon
Amazon
AMZN
+$367M
5
ORCL icon
Oracle
ORCL
+$306M

Sector Composition

Rank Sector Weight
1 Financials 34.19%
2 Communication Services 15.33%
3 Consumer Discretionary 9.92%
4 Healthcare 9.75%
5 Technology 9.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAT icon
126
Caterpillar
CAT
$375B
$532K ﹤0.01%
1,800
TMUS icon
127
T-Mobile US
TMUS
$185B
$513K ﹤0.01%
3,200
-4,340
-58% -$642K
IBDQ
128
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$498K ﹤0.01%
+20,114
New +$493K
VTV icon
129
Vanguard Morningstar Value ETF
VTV
$188B
$440K ﹤0.01%
+2,945
New +$414K
ABBV icon
130
AbbVie
ABBV
$443B
$434K ﹤0.01%
2,800
-455
-14% -$66.3K
HWM icon
131
Howmet Aerospace
HWM
$113B
$406K ﹤0.01%
7,500
IBDS icon
132
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.84B
$379K ﹤0.01%
+15,825
New +$369K
REYN icon
133
Reynolds Consumer Products
REYN
$5.26B
$349K ﹤0.01%
13,000
-1,850
-12% -$48.3K
VUG icon
134
Vanguard Morningstar Growth ETF
VUG
$220B
$332K ﹤0.01%
+6,408
New +$309K
CPRI icon
135
Capri Holdings
CPRI
$1.83B
$327K ﹤0.01%
6,500
-5,500
-46% -$274K
THC icon
136
Tenet Healthcare
THC
$20.5B
$295K ﹤0.01%
3,900
VGK icon
137
Vanguard FTSE Europe ETF
VGK
$30.7B
$266K ﹤0.01%
+4,128
New +$247K
VPL icon
138
Vanguard FTSE Pacific ETF
VPL
$8.08B
$259K ﹤0.01%
+3,589
New +$244K
IBDP
139
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$254K ﹤0.01%
+10,208
New +$253K
VO icon
140
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$251K ﹤0.01%
+4,316
New +$231K
VB icon
141
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$250K ﹤0.01%
+1,174
New +$226K
VWO icon
142
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$197K ﹤0.01%
+4,788
New +$190K
EFA icon
143
iShares MSCI EAFE ETF
EFA
$78B
$50.4K ﹤0.01%
+669
New +$47.3K
KDP icon
144
Keurig Dr Pepper
KDP
$42.3B
-9,140
Closed -$289K
NOV icon
145
NOV
NOV
$6.93B
-838,300
Closed -$17.5M
PHM icon
146
Pultegroup
PHM
$24.1B
-1,954,842
Closed -$145M
VIPS icon
147
Vipshop
VIPS
$7.37B
-5,749,901
Closed -$92.1M
WBD icon
148
CALL
Warner Bros
WBD
$65.9B
-10,000,000
Closed -$109M

Similar funds

Harris Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Harris Associates held 148 positions worth $58B, up 13% from $51.4B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Harris Associates's Q4 2023 filing shows 14 new, 45 increased, 73 reduced and 5 closed positions. Its largest new stake was Agilent Technologies: 2,342,383 shares worth $326M. The largest sale was Parker-Hannifin, an estimated $436M.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 32% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Harris Associates's largest Q4 2023 buy was Agilent Technologies: 2,342,383 shares worth $326M.
  • Harris Associates added most to Phillips 66 in Q4 2023, an estimated $597M increase.
  • Harris Associates's biggest Q4 2023 reduction was Parker-Hannifin, cutting an estimated $436M.
  • Harris Associates fully exited Pultegroup in Q4 2023, selling an estimated $145M.
  • Harris Associates's ten largest holdings make up 36% of its $58B portfolio in Q4 2023.
  • Harris Associates opened 14 new positions and closed 5 in Q4 2023.
  • Harris Associates's portfolio value rose 13% quarter-over-quarter to $58B.

Based on Harris Associates's 13F filing for Q4 2023, filed 14 Feb 2024.